Bortezomib-Induced Reversible Cardiomyopathy: Recovered With Guideline-Directed Medical Therapy

Bortezomib (BTZ) is a proteasome inhibitor (PI) used for the treatment of several hematologic malignancies, including multiple myeloma (MM), and various lymphomas including mantle cell lymphoma (MCL). It acts via disruption of the ubiquitin-proteasome pathway which plays a major role in regulating c...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundaravel, Swethika H, Marar, Rosalyn I, Abbasi, Muhannad A, Baljevic, Muhamed, Stone, Jeremy R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742456/
https://www.ncbi.nlm.nih.gov/pubmed/35024253
http://dx.doi.org/10.7759/cureus.20295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742456/
https://www.ncbi.nlm.nih.gov/pubmed/35024253
http://dx.doi.org/10.7759/cureus.20295

Ejemplares similares